Secunderabad Chronicle

3D Bioprinting Market Size 2022 Global Industry Analysis by Trends, Future Demands, Top Key Players and Forecast Till 2027

 Breaking News
  • No posts were found

3D Bioprinting Market Size 2022 Global Industry Analysis by Trends, Future Demands, Top Key Players and Forecast Till 2027

May 15
19:32 2023
3D Bioprinting Market Size 2022 Global Industry Analysis by Trends, Future Demands, Top Key Players and Forecast Till 2027
3D Bioprinting Market is Expected to Reach $3.3 billion | MarketsandMarkets™
3D Bioprinting market in terms of revenue was estimated to be worth $1.3 billion in 2022 and is poised to reach $3.3 billion by 2027, growing at a CAGR of 20.8% from 2022 to 2027 according to a latest report published by MarketsandMarkets™.

The Global 3D Bioprinting Market in terms of revenue was estimated to be worth $1.3 billion in 2022 and is poised to reach $3.3 billion by 2027, growing at a CAGR of 20.8% from 2022 to 2027. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market. Factors such as technological advancements in 3D bioprinters and biomaterials, increasing use of 3D bioprinting in the pharmaceutical and cosmetology industries, and rising public and private funding to support bioprinting research activities are driving market growth. However, a dearth of skilled professionals and high development and production costs are restraining the growth of this market.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=170201787

Browse in-depth TOC on “3D Bioprinting Market”

297 – Tables

38 – Figures

270 – Pages

Drivers: Increasing use of 3D bioprinting in the pharmaceutical and cosmetic industries:

The increasing use of 3D bioprinting in the pharmaceutical and cosmetic industries has been a major driver of the market. 3D bioprinting enables the production of complex 3D structures, which are difficult to produce using traditional methods. This has enabled the production of complex drug molecules and formulations, as well as cosmetic products such as artificial skin, hair follicles, and other tissues. The increasing demand for 3D bioprinted products in the pharmaceutical and cosmetic industries has been a major driver of the market.

Opportunities: Rising demand for organ transplants:

3D bioprinting is a rapidly growing field in the medical industry. It is a process of creating living tissues and organs from a computer aided design model. This technology has the potential to revolutionize the way medical treatments are done. 3D bioprinting has the potential to address the ever increasing demand for organ transplants, which is currently outstripping the available donor organs. This technology can provide an ethical and efficient approach to creating organs for transplant. Additionally, 3D bioprinting has the potential to reduce costs associated with organ transplants. As the technology continues to improve, the market for 3D bioprinting is expected to grow significantly in the coming years.

Challenges: Process control and understanding of 3D bioprinters

One of the major challenges in the market is the process control and understanding of 3D bioprinters. The 3D bioprinters require precise control over the material and process parameters, such as temperature, pressure, and composition of the material being printed. Due to the complexity of the process, it can be difficult to understand and control the bioprinting process. This can lead to inaccurate results and potential damage to the printed material. To address this challenge, 3D bioprinting companies have developed dedicated software that can help manage the printing process and optimize its settings. Additionally, the use of automated process control systems can help ensure more consistent results. Additionally, research is being conducted to improve the understanding of the 3D bioprinting process and develop improved bioprinting materials.

The component segment and 3D bioprinters subsegment dominated the 3D bioprinting market.

On the basis of component, the market is segmented into 3D bioprinters and bioinks. 3D bioprinters accounted for the largest market share. Factors such as technological advancements and the growing demand for organ transplants are driving the growth of this segment.

Inquiry Before Buying @

https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=170201787

The 3D Bioprinters segment accounted for the largest share in the 3D Bioprinting market, by component, during the forecast period.

Based on component, the 3D bioprinting market is segmented into 3D bioprinters and bioinks. 3D bioprinters accounted for the larger market share in 2021. Technological advancements and the growing demand for organ transplants are the major factors driving the growth of this segment.

The Research applications subsegment accounted for the largest share of the application segment in the 3D Bioprinting market in 2021.

Based on application, the 3D bioprinting market is segmented into research applications and clinical applications. The research applications segment accounted for the larger share of the 3D bioprinting market in 2021. The market for research applications is further segmented into drug research, regenerative medicine, and 3D cell culture. Among these, the drug research segment accounted for the largest share of the market in 2021, due to the growing adoption of 3D bioprinting technology by biopharmaceutical companies.

The Research Organizations and Academic Institutes subsegment accounted for the largest share of the application segment in the 3D bioprinting market in 2021.

On the basis of end users, the 3D bioprinting market is segmented into research organizations and academic institutes, biopharmaceutical companies, and hospitals. Research organizations and academic institutes form the largest and fastest-growing end-user segment in this market. This can be attributed to the increasing collaborations between academic & research institutes and key market players for developing novel 3D-bioprinted products.

Key Player

Key players in the global 3D Bioprinting Market include BICO Group AB (US), Organovo Holdings Inc. (US), Allevi, Inc. (part of 3D Systems, Inc.) (US), CollPlant Biotechnologies Ltd. (Israel), regenHU (Switzerland), EnvisionTEC GmbH (part of Desktop Metal, Inc.) (Germany), Aspect Biosystems Ltd. (Canada), Advanced Solutions Life Sciences, LLC (US), and Regenovo Biotechnology Co., Ltd. (part of Shining 3D Tech Co., Ltd.) (China).

 North America is the largest region and Asia Pacific is the fastest-growing region of the 3D Bioprinting market in 2021.

Based on region, the 3D bioprinting market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2021, North America dominated the market, followed by Europe. The significant government and private investments to develop advanced 3D bioprinting technologies, the high adoption rate of these technologies, and the presence of key market players in the region are responsible for the large share of North America in the 3D bioprinting market. The Asia Pacific market is projected to grow at the highest CAGR during the forecast period.

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=170201787

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Aashish Mehra
Email: Send Email
Phone: 18886006441
Address:630 Dundee Road Suite 430
City: Northbrook
State: IL 60062
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/3d-bioprinting-market-170201787.html

Related Articles